Celldex Therapeutics Inc (CLDX) — Long-term Investment Intensity
Celldex Therapeutics Inc (CLDX) has a Long-term Investment Intensity of 1.2% as of December 2018. Long-term investments of $1.80 Million represent 1.2% of total assets of $155.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See shareholders equity of Celldex Therapeutics Inc for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Celldex Therapeutics Inc Long-term Investment Intensity (2017–2018)
This chart shows how Celldex Therapeutics Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of December 2018, the intensity stands at 1.2%, reflecting long-term investments of $1.80 Million against total assets of $155.81 Million USD. Also explore Celldex Therapeutics Inc asset portfolio for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Celldex Therapeutics Inc (2017–2018)
The table below presents the year-by-year Long-term Investment Intensity for Celldex Therapeutics Inc from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see CLDX market cap overview.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 1.2% | $1.80 Million | $155.81 Million | ▲ +0.6 pp |
| 2017 | 0.6% | $1.80 Million | $315.62 Million | — |